Inloggad som:
avslutad_ASC4First
Är du som patient intresserad av mer information om en studie, kontakta din behandlande läkare.
avslutad_ASC4First
A phase III, multi-center, open-label, randomized study of oral asciminib versus Investigator selected TKI in patients with newly diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase
A phase III, multi-center, open-label, randomized study of oral asciminib versus Investigator selected TKI in patients with newly diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase
Karolinska Universitetssjukhuset / Hematologisk vård
Mer information om studien för vårdgivare
Studien ändrades senast: (2025-05-05)